Indication
Treatment of lung and pancreatic cancers
Official EMA Resources
View on EMA (ema.europa.eu)AI Drug & Interaction Analysis
Loading your page…
Loading your page…
Carcinoma, Non-Small-Cell Lung;Pancreatic Neoplasms
Marketing Authorisation Holder: Accord Healthcare S.L.U.
INN: erlotinib
AI Drug & Interaction Analysis
Free account required
Ask Osler about Erlotinib Accord: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.